News & Analysis on Clinical Trial Services & Contract Research And Development
Cytel: acquisition of Purple Squirrel Economics
By Jenni Spinner
- Last updated on
Life-sciences analytics specialist Cytel has purchased Purple Squirrel Economics. The acquisition is designed to bolster Cytel’s health economics outcomes research (HEOR) expertise.
Joshua Schultz, Cytel CEO, said, “Purple Squirrel Economics is a highly specialized HEOR team, and we are excited to welcome them into Cytel. By combining the power, knowledge, and expertise of Cytel, Ingress, and MTEK Sciences, we look forward to further increasing the reach of our innovative real world and advanced analytics services to help companies derive clinical insights as well as demonstrate and communicate value, ultimately aiding the global effort to bring medicines to patients more quickly.”